As CAXII is a promising therapeutic target for cancer treatment, and impact of Tiliroside on the quantity of CAXII in the treated cells was tested using the Human carbonic anhydrase 12 (CA-12) ELISA Kit. This evidence concerns the gene CA12 and cancer.